ClinicalTrials.gg
Not yet recruitingNCT07892066Updated Oct 23, 2026

Comparative Effects of Soft Tissue Mobilization and Pressure Therapy With and Without Dynamic Cupping on on Pain and Disability in Patients With Thoracic Back Pain.

An interventional study of Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping in Back Pain, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
All
01

Study summary

This study aims to compare the sequential effects of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP), with and without Directional Dynamic Cupping, in patients with thoracic back pain. The study will evaluate the effectiveness of these treatment approaches in reducing pain, improving functional ability, and minimizing disability during daily activities.

02

Conditions studied

  • Back Pain

Browse trials for

Keywords

  • Instrument-assisted soft tissue mobilization
  • Manual therapy
  • Functional disability
  • Directional dynamic cupping
  • Transverse oscillatory pressure
03

In context

Back Pain

2,389 studies on the registry are indexed under Back Pain; 282 are open to participants now.

This study's planned enrollment of 64 is close to the median of 60 across 1,952 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 6 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Non-specific chronic thoracic back pain patients aged between 25 to 45 Both genders. Mild to moderate thoracic back pain with NPRS pain score value of between 3/10 6/10. Pain from at least past three months (12 weeks). Pain localized to thoracic region T1-T12, no radiating pain Willing to provide informed consent and attend all sessions

Exclusion criteria

Exclusion Criteria:

Pathological conditions or diagnosed with disk herniation, spinal stenosis, spondylolisthesis, and spondylitis and other medical illnesses such as tumor, lungs disease, and visceral disease or any other red flag condition Referred pain: cervical/lumbar radiculopathy History of cardio-respiratory disease, thoracic surgery, or ribs fracture fixation surgery \<6 months Bleeding disorder/anticoagulant use, skin infection, hypersensitivity at treatment area Pregnancy, BMI >35.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Active comparator
    Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP)

    Other: Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP)

  • Experimental
    Instrument assisted soft tissue, Transvers oscillatory pressure and Directional dynamic cupping

    Other: Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping

Interventions

  • OtherInstrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP)

    Participants will receive Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP) in sitting or prone positions, combined with alternating 10-second resisted isometric trunk flexion-extension contractions. Conventional therapy includes a hot pack for 10 minutes and muscle stretching (10 repetitions, 30-second hold each).

  • OtherInstrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping

    Participants will receive a moist hot pack over the thoracic region for 10-15 minutes, followed by IASTM using the Graston tool for 5-8 minutes. Transverse Oscillatory Pressure (TOP) will be applied for 3-5 minutes per affected segment, according to patient tolerance. Directional Dynamic Cupping will then be performed over the thoracic paraspinal muscles for 5-10 minutes with controlled suction and gliding movements.

06

What researchers measure

Primary outcomes

  1. Numerical Pain Rating Scale

    The 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs).

    Time frame: Baseline , after 2 weeks and 4 weeks post treatment

  2. FUNCTION RATING INDEX

    The Functional Rating Index (FRI) consists of 10 items: pain intensity, pain frequency, sleep, personal care, travel, work, leisure activities, lifting, walking, and standing. Two items assess pain characteristics, while eight assess spinal functional limitations in daily activities. Each item is scored from 0 (no pain/full function) to 4 (maximum pain/total disability), with higher scores indicating greater disability.

    Time frame: Baseline , after 2 weeks and 4 weeks post treatment

  3. BUBBLE INCLINOMETER

    Lumbar range of motion (ROM) will be measured in standing using bubble inclinometers, with S1 and T12 as reference points for flexion and extension, and T12 for lateral flexion. Two inclinometers will assess forward flexion, while one will assess extension and lateral flexion; actual flexion and extension ROM will be calculated by subtracting the lower inclinometer reading from the upper reading.

    Time frame: Baseline , after 2 weeks and 4 weeks post treatment

07

Study locations

1 site
  • University of Management & Technology
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: Yes — The result data collected de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Six months after the publication of the manuscript.

Access criteria: Data can be requested from the corresponding author.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 933 non-industry interventional studies with no phase under Back Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 2 months is below that.

Counting every sponsor, half of 997 studies reached it within 11 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2026
First posted
Oct 23, 2026
StartEst.
Oct 20, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07892066
Lead sponsor
University of Management and Technology Lahore
Responsible party
Salman Bashir (Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Oct 23, 2026
Start date
Oct 20, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion